Public health investigations required for protecting the population against novel coronaviruses

Eastern Mediterranean Health Journal

Volumn 19, Issue SUPPL.1, 2013, Pages 61-67

  Nicoll, A ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSISTED VENTILATION; CORONAVIRUS; CORONAVIRUS INFECTION; DISEASE SURVEILLANCE; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION CONTROL; NONHUMAN; PUBLIC HEALTH; SARS CORONAVIRUS; SEASONAL INFLUENZA; SEROLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; VIROLOGY; VIRUS TRANSMISSION;

EID: 84939905662     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2013.19.supp1.s61     Document Type: Article

References (27)

1. Rapid risk assessment: severe respiratory disease associated with a novel coronavirus, 19 February 2013. Stockholm, European Centre for Disease Prevention and Control, 2013 (http://ecdc.europa.eu/en/publications/Publications/novel-coronavirus-rapid-risk-assessment-update.pdf, accessed 11 May 2013).
2. Danielsson N, on behalf of the ECDC Internal Response Team. Catchpole M. Novel coronavirus associated with severe respiratory disease: Case definition and public health measures. Eurosurveillance, 2012, 17(39):pii 20282.
3. Heymann D, Mackenzie J, Peiris M. SARS legacy: outbreak reporting is expected and respected Lancet, 2013, 381(9869):779-781.
4. Eurosurveillance editorial team. Note from the editors: A new virus bringing back memories from the past. Eurosurveillance, 2012, 17(39):pii 20284.
5. Consensus document on the epidemiology of severe acute respiratory syndrome. Geneva, World Health Organization, Department of Communicable Disease Surveillance and Response 2003 (WHO/CDS/CSR/GAR/2003.11) (http://www.who.int/ csr/sars/en/WHOconsensus.pdf, accessed 11 May 2013).
6. Health Protection Agency (HPA) UK, Novel Coronavirus Investigation team. Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013. Eurosurveillance, 2013;18(11): pii 20427
7. Update: Outbreak of Severe Acute Respiratory Syndrome-Worldwide, 2003. Morbidity and Mortality Weekly Report (MMWR), 2003, 52(12):241-248.
8. Genetic sequence information for scientists about the novel coronavirus 2012. Whole Genome Sequence-Added 18th February 2013. London, Public Health England, Health Protection Agency 2013 (http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/NovelCoronavirus2012/ respPartialgeneticsequenceofnovelcoronavirus/) accessed 11 May 2013.
9. Cotten M et al. Full-genome deep sequencing and phylogenetic analysis of novel human betacoronavirus. Emerging Infectious Diseases, 2013, 19(5) (http://wwwnc.cdc.gov/eid/ article/19/5/13-0057_article.htm, accessed 11 May 2013).
10. Annan A et al. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe.[Internet]. Emerging Infectious Diseases, 2013, 19:456-459.
11. Raj VS et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature, 2013, 495:251-254 (http://www.nature.com/nature/journal/v495/n7440/ pdf/nature12005.pdf, accessed 11 May 2011).
12. Chan JP et al. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications on disease pathogenesis and clinical manifestation. Journal of Infectious Diseases. (2013) 207(11):1743-1752.
13. Müller M et al. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. mBio, 2012, 3(6) (http:// mbio.asm.org/content/3/6/e00515-12.long, accessed 11 May 2013).
14. Mackintosh K. A new virulent human coronavirus: How much does tissue culture tropism tell us? Journal of Infectious Diseases (Advance Access), 2013 (http://jid.oxfordjournals.org/content/early/2013/03/24/infdis.jit125.full.pdf+html, accessed 11 May 2013).
15. Li W et al. Bats are natural reservoirs of SARS-like coronaviruses. Science, 2005, 310:676-679.
16. Buchholz U et al. Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Eurosurveillance, 2013, 18(8):20406 (http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20406, accessed 11 May 2013).
17. Pebody RG et al. The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Eurosurveillance, 2012, 17(40):pii 20292.
18. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (Based on data as of the 31 December 2003.). Geneva, World Health Organization, Global Health and Response, 2003 (http://www.who.int/csr/sars/ country/table2004_04_21/en/index.html, accessed 11 May 2013).
19. Anderson RM et al. Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 2004, 359:1091-1105.
20. Peiris JS et al. The severe acute respiratory syndrome. New England Journal of Medicine, 2003, 349:2431-2441.
21. "The First Few Hundred (FF100)" Enhanced Case and Contact Protocol v4.0. Epidemiological protocols for comprehensive assessment of early novel coronavirus cases and their close contacts in the United Kingdom. London, Health Protection Agency, 2012 (http://www.hpa.org.uk/webc/HPAwebFile/ HPAweb_C/1317136300809, accessed 11 May 2013).
22. Van Kerkhove M et al. on behalf of the CONSISE steering committee. The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy. Influenza and Other Respiratory Viruses, 2012, 7(3).
23. Reusken C et al. Specific serology for emerging human coronaviruses by protein microarray. Eurosurveillance, 2013, 18:pii 20441.)
24. Van Kerkhove M. CONSISE and avian influenza H7N9. CONSISE Working Draft Protocols for influenza. London, CONSISE The Consortium for the Standardization of Influenza Seroepidemiology, 2013 (http://consise.tghn.org/articles/consise-andavian-influenza-h7n9/, accessed 11 May 2013).
25. Longuère K-S. ISARIC and WHO SARI and Natural History Protocols. Oxford, ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium), 2013 (http://isaric.tghn. org/articles/isaric-and-who-sari-and-natural-history-protocols/, accessed 11 May 2013).
26. Biggar RJ et al. Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya. East Africa International Journal of Cancer, 1985, 35(6):763-767 (http://onlinelibrary.wiley.com/doi/10.1002/ ijc.2910350611/abstract, accessed 11 May 2013).
27. International Health Regulations, 2005, 2nd ed. Geneva, World Health Organization, 2008 (http://whqlibdoc.who.int/publications/2008/9789241580410_eng.pdf, accessed 11 May 2013).